trending Market Intelligence /marketintelligence/en/news-insights/trending/aVRLb6oxRNJiqYfAtYyb7g2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

BioTime changes name to Lineage Cell Therapeutics

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

BioTime changes name to Lineage Cell Therapeutics

BioTime Inc., a biotechnology company that focuses on developing therapies for unmet medical needs, is changing its name to Lineage Cell Therapeutics Inc.

The company's ticker will change to LCTX, effective the same day as the name change on Aug. 12, the company said July 31.

Alameda, Calif.-based BioTime said the change reflects its extensive cell therapy platform.